result question manag
januari
summari result
lfl sale growth meaning ahead consensu impli factset consensu
driven price volum declin deliveri reflect
except strong quarter hill lfl sale growth turn toward bottom-
line gross margin declin consensu ebit margin declin
consensu ep ahead consensu tax
rate rel low quarter
highlight colgat confid achiev price need
stem roll-ov price price alreadi accept
revis ep driven lower margin turn reflect
colgat appear turn posit corner struggl valuat given
believ top-lin growth profil
maintain under-perform rate target price remain unchang
question manag
expect long-term organ sale growth rang
notwithstand materi increas invest keep mind
achiev futur
exan bnpp estim thomson reuter consensu list currenc dividend reinvest yearli averag price fy end
date time london time invest recommend finalis may differ date time broad dissemin
websit appendix analyst certif import disclosur non-u research analyst disclosur
result question
summari result
lfl sale growth meaning ahead consensu impli factset
consensu driven price volum declin analys
driver behind top-lin develop standout far hill lfl
sale growth cf hill asid sale trend broadli in-
line expect except north america rel weak
lfl sale growth reflect volum declin price
explain north american perform colgat comment
impact phase promot move
turn toward bottom-lin gross margin declin consensu
ebit margin declin consensu ep
ahead consensu tax rate low quarter
cf
figur outlin main element releas rel
consensu expect
figur summari result rel expect
varianc
colgat offer follow guidanc pointer wrt
sale growth flat low-singl digit
advertis increas invest absolut sale
explain guidanc colgat comment
outlook reflect increas raw materi price increas tax rate
year-over-year uncertainti surround global economi exchang rate
price given plan increas invest behind brand drive
acceler organ sale growth believ earn outlook
highlight main newsworthi item may easili glean
quick read releas
price around price need either roll-ov price
price alreadi accept trade total
hill scienc diet relaunch colgat confid price need
realis
innov scale colgat innov programm typic
relaunch colgat total global share hill scienc diet hill
signific top activ adjac natur well
broad array normal innov
market growth market growth flat europ north america
categori growth slow littl us emerg market global
market growth rang
lfl lfl sale growth balanc price
volum price led
yellow vest yellow vest protest franc impact european growth
around quarter
financi gross margin expect increas
tax rate expect rang
cost colgat plan commod cost inflat
like weight top fx headwind full
advertis meaning increas advertis advertis
spend full year expect increas absolut term sale
china sequenti improv china yoy sale
trend remain neg destock work look forward
colgat expect continu see sequenti improv
busi return growth
plc elta md recent profession skin care acquisit
includ north american lfl sale growth prioriti first expand
exist locat new locat move retail channel possibl
point
latin america mexico brazil saw sequenti improv mexican
market becom less promot categori growth start come back
brazil categori growth modest heighten promot activ continu
market place
north american promot shift shift major promot
impact lfl sale growth north america
figur outlin revis previou ep estim
figur summari ep revis
varianc previou estim primarili driven lower ebit margin
assumpt turn reflect estim materi increas
invest colgat qualit flag
colgat appear turn posit corner struggl valuat
given believ top-lin growth profil
rate target price
maintain under-perform rate previous argu colgat
trade in-lin hpc sector benchmark ep see
practic guid light like improv top-lin trend believ
modest increment sector benchmark multipl sustain keep
mind revis target multipl consequ appli
revis ep estim target price remain unchang
question manag
expect long-term organ sale growth rang
notwithstand materi increas invest keep mind
organ sale growth achiev futur
pleas quantifi impact argentina price upon group latin
american lfl sale growth
pleas talk price strategi china
prolong neg impact upon volum trend market
henkel guid earn increas invest
likewis see risk see peer becom
think beyond think global growth
effici programm given shift alreadi made still scope
meaning sg effici
believ impend merger glaxo consum health
consum mean face formid competitor oral
see evid growth smaller player start abat
bigger player start embrac natur space
confid face growth issu
start comp year except innov back materi pick-up
comment number occas wrt expand
elmex meridol pleas remind us specif move
made brand
guid lfl sale growth risk envisag
make think possibl could arriv bottom end rang
expect see materi move sector
appreci buy spot oil guidanc commod
inflat exclud fx feel rel conserv main assumpt
behind
pleas talk learn gain invest
hubbl bombay shave club deploy elsewher
given taken materi price increas china price
asia pacif region low
sustain growth rate hill one-off factor
influenc growth busi quarter
pleas see overleaf revis segment sale profit loss account
profit tax
profit taxat non-gaap
profit continu oper
profit continu oper non-gaap
basic number share averag
fulli dilut number share averag
pay-out ratio basic non-gaap
dividend cover basic non-gaap
depreci amortis
net profit margin minor non-gaap
invest case valuat risk
colgat appear turn posit corner struggl valuat
given believ top-lin growth profil
valu colgat ep
upsid
risk would highlight includ possibl colgat subject near-
downsid
risk would highlight includ possibl volum trend weaker
anticip consequ price action colgat take
cross mikheil omanadz jeff stent heidi vesterinen author contributor report herebi certifi view express report
accur reflect person view compani compani secur discuss report part compens
directli indirectli relat specif recommend view express research report
research analyst name involv prepar research report research analyst exan limit exan sa associ person
exan inc thu regist qualifi research analyst financi industri regulatori author finra new york stock
exchang nyse non-u analyst subject nasd rule nyse rule restrict commun subject compani
public appear trade secur held research analyst account
exan sa regul autorit de march financi amf franc exan limit authoris regul financi conduct author
unit kingdom exan inc regul finra secur exchang commiss unit state
research analyst respons prepar report receiv compens base upon variou factor includ overal firm revenu may
research analyst respons prepar report member household may relationship compani cover
research report describ number disclosur tabl immedi indic disclosur appli research
analyst respons prepar research report
research analyst respons prepar report member his/her household has/hav financi interest secur subject
company/i indic previou tabl
research analyst respons prepar report member his/her household serv offic director advisori board member
subject company/i indic previou tabl
research analyst respons prepar report receiv compens subject company/i indic previou tabl
exan sa exan limit exan inc collect exan may relationship compani cover research report describ
number disclosur tabl immedi indic disclosur appli exan relationship subject company/i
exan benefici own class common equiti secur subject company/i
exan manag co-manag offer equiti secur subject company/i past month
exan receiv compens invest bank servic subject company/i past month invest bank servic
exan regard subject company/i exan distributor underwrit equiti secur offer managed-or co-manag bnp
pariba bnp pariba manag co-manag offer equiti secur subject company/i
exan expect receiv intend seek compens invest bank servic subject company/i next month
exan sa and/or exan limit are/i market maker and/or liquid provid secur subject company/i
exan inc receiv compens product servic invest bank servic subject company/i past month
exan inc invest bank servic client relationship subject company/i past month
exan inc non-invest bank securities-rel client relationship subject company/i past month
exan inc non-securities-rel servic relationship subject company/i past month
exan inc market maker secur subject company/i
exan benefici own least long short posit subject company/i
section report research summari target price rate remov present subject company/i prior distribut
sole purpos verifi accuraci factual statement
follow present section report subject compani conclus amend
commit transpar potenti conflict interest bnp pariba
bnp pariba bnpp hold materi ownership interest variou exan entiti exan bnpp enter agreement maintain
independ exan research report bnpp research report publish brand name exan bnp pariba nevertheless sake
transpar separ identifi potenti conflict interest bnpp regard company/ cover research document
